ps09-9020301supp11 final amend i 01.31.11.doc

AMENDMENT I (as of 01/28/2011):

1. Pgs. 2 & 15: Application deadline extended to March 21, 2011.

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention (CDC) Comprehensive STD Prevention Systems-Infertility Prevention Project

I. AUTHORIZATION AND INTENT

Announcement Type: Supplement Funding Opportunity Number: CDC-RFA-PS09-9020301SUPP11 Catalog of Federal Domestic Assistance Number: 93.977 Key Date:

Application Deadline Date: March 21, 2011, 5:00pm Eastern Standard Time Authority:

This program is authorized under section 318 (a) (b) (c) of the Public Health Service Act [42 U.S.C. Section 247c (a) (b) and (c)] and section 301 of the public Health Service Act [42 U.S.C. Section 241], as amended. Regulations governing the implementation of this legislation are covered under 42 CFR Part 51b, Subpart A Purpose:

The goal of this supplement is to provide additional support to project area STD prevention programs for the expansion of Chlamydia and gonorrhea (CT/GC) screening and treatment services. Plans for targeted CT/GC screening and treatment activities should reflect program decisions based on local epidemiology and disease prevalence estimates.

This program addresses “Healthy People 2010” focus area 25, Sexually Transmitted Diseases (STD), http://www.healthypeople.gov/document/html/volume2/25stds.htm. It also supports the overarching goals of Healthy People 2010: (1) to increase years and quality of healthy life and (2) eliminate disparities among subgroups of the population.

Measurable outcomes of the program will be in alignment with the following performance goals for the National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (NCHHSTP): 1) Reduction of Pelvic Inflammatory Disease (PID).

This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be reviewed. For the definition of research, please see the CDC Web site at the following Internet address: http://www.cdc.gov/od/science/regs/hrpp/researchDefinition.htm

II. PROGRAM IMPLEMENTATION

Recipient Activities:

The goal of this supplement is to provide additional support to project area STD prevention programs for the expansion of Chlamydia and gonorrhea (CT/GC) screening and treatment services. Plans for targeted CT/GC screening and treatment activities should reflect program decisions based on local epidemiology and disease prevalence estimates.

Funds may be used towards the purchase of CT/GC screening and treatment supplies.

Other recipient activity responsibilities should be compatible with those outlined in Funding Opportunity Number PS09-902.

CDC Activities:

In a cooperative agreement, CDC staff are substantially involved in program activities above and beyond routine grant monitoring.

CDC activities for this program are as follows:

1. Provide consultation and technical assistance (TA) to health departments on various aspects of their STD prevention programs (e.g., performance measurement, program evaluation, outbreak response planning). Program consultants will facilitate the joint development, implementation, and evaluation of grantee-specific Program Improvement Plans.

2. Work with grantees to assess training needs and provide training to managers, supervisors, and disease intervention staff, or other prevention programs, including hepatitis coordinators, HIV program managers, reproductive health representatives, and family planning partners either directly or through the NNPTCs or other training partners.

3. Disseminate current information, including national surveillance data, prevention, and management recommendations in all areas of STD prevention, including STD-related infertility prevention and syphilis elimination.

4. Support and facilitate program collaboration with other CDC programs and HHS offices to enhance and improve integration of services.

5. Monitor grantee progress toward achieving stated target levels of performance, from objectives and Performance Measures, and work with the grantee to make improvements if target levels are not met through consultation via site visits, email, telephone, and review of progress reports.

6. Oversee the recruitment, development, and management of all directly assigned STD prevention field staff.

7. Provide up-to-date national guidance in essential program functions (e.g., Community and Individual Behavioral Change Services, Medical and Laboratory Services, Partner Services, Leadership and Program Management, Surveillance and Data Management, Training and Professional development, STD Outbreak response, and Program Evaluation) to facilitate local program activities as well as local and national public health policy. These can be downloaded from www.cdc.gov/std.

8. Provide programmatic consultation, technical assistance, and reference/diagnostic services for STDs through reference laboratory activities.

9. Support and facilitate program collaboration to enhance and improve integration of services.

III. AWARD INFORMATION AND REQUIREMENTS

Type of Award: Cooperative Agreement. CDC substantial involvement in this program appears in the Activities Section above.

Award Mechanism: U30- Preventive Health Service: Venereal Disease Research, Demonstration, and Public Information and Education Projects Fiscal Year Funds: 2011 Approximate Current Fiscal Year Funding: $730,000 Approximate Total Project Period Funding: $730,000 Approximate Number of Awards: 64 Approximate Average Award: $11,406 Floor of Individual Award Range: $277 Ceiling of Individual Award Range: $51,648 Anticipated Award Date: April 1, 2011 Budget Period Length: 11 months Project Period Length: 8 months Throughout the project period, CDC’s commitment to continuation of awards will be conditioned on the availability of funds, evidence of satisfactory progress by the recipient (as documented in required reports), and the determination that continued funding is in the best interest of the Federal government.

IV. ELIGIBILITY

Eligible applicants are the 64 official public health agencies that are current recipients of project grants for Preventative Health Services-Sexually Transmitted Disease Control grants, IPP component (The Chicago project area does not receive IPP funds). These applicants have the necessary infrastructure in place to perform the activities required and have the experience needed to successfully complete the required functions.

SPECIAL ELIGIBILITY CRITERIA: Licensing/Credential/Permits

Cost Sharing or Matching

Cost sharing or matching funds are not required for this program.

Maintenance of Effort

Maintenance of Effort is not required for this program.

Other

If a funding amount greater than the ceiling of the award range is requested, the application will be considered non-responsive and will not be entered into the review process. The applicant will be notified that the application did not meet the eligibility requirements.

Note: Title 2 of the United States Code Section 1611 states that an organization described in Section 501(c)(4) of the Internal Revenue Code that engages in lobbying activities is not eligible to receive Federal funds constituting a grant, loan, or an award.

Intergovernmental Review of Applications

Executive Order 12372 does not apply to this program.

V. Application Content

Application for these supplemental funds should be no more than 5 pages in length (excluding the budget and justification) and meet the narrative requirements as outlined in Funding Opportunity Number PS09-902 for line spacing, font size, and margin size.

1. Narrative:

The Narrative should include a program plan including a brief description of the project area’s CT/GC epidemiology and the applicant would use their local data to plan for targeted CT/GC screening and treatment activities. The narrative should describe the program experience and organizational capacity to plan, deliver, and evaluate targeted CT/GC screening and treatment activities. The applicant should describe in sufficient detail plans to collaborate with other IPP partners. An evaluation plan should be included and describe ways to measure process and impact of expanded targeted CT/GC screening and treatment activities.

2. Budget and Staffing Breakdown and Justification:

a. Provide a detailed budget for each proposed activity. Justify all operating expenses in relation to the planned activities and stated objectives. CDC may not approve or fund all proposed activities. Be precise about the program purpose of each budget item and itemize calculations wherever appropriate.

b. For each contract and consultant contained within the application budget: describe the type(s) of organizations or parties to be selected and the method of selection; identify the specific contractor(s), if known; describe the services to be performed, and justify the use of a third party to perform these services; provide a breakdown of, and justification for, the estimated costs of the contracts and consultants; specify the period of performance; and describe the methods to be used for contract monitoring.

Note:

If indirect costs are requested, applicants must provide a copy of their organization’s current negotiated Federal indirect cost rate agreement.

CDC Assurances and Certifications can be found on the CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/grants/foamain.shtm Other Requirements

Letter of Intent (LOI):

A letter of intent is not applicable to this funding opportunity announcement.

A Project Abstract must be completed in the Grants.gov application forms. The Project Abstract must contain a summary of the proposed activity suitable for dissemination to the public. It should be a self-contained description of the project and should contain a statement of objectives and methods to be employed. It should be informative to other persons working in the same or related fields and insofar as possible understandable to a technically literate lay reader. This abstract must not include any proprietary/confidential information.

A Project Narrative must be submitted with the application forms. The project narrative must be uploaded in a PDF file format when submitting via Grants.gov. The narrative must be submitted in the following format:

· Maximum number of pages: 5 (excluding budget and justification). If your narrative exceeds the page limit, only the first pages which are within the page limit will be reviewed.

· Font size: 12 point unreduced, Times New Roman

· Single spaced

· Page margin size: One inch

· Number all narrative pages; not to exceed the maximum number of pages.

The narrative should address activities to be conducted over the entire project period and must include the following items in the order listed:

1. A program plan including a brief description of the project area’s CT/GC epidemiology and how the applicant would use their local data to plan for targeted CT/GC screening and treatment activities.

2. A description of the program’s experience and organizational capacity to plan, deliver, and evaluate targeted CT/GC screening and treatment activities.

3. The applicant should describe in sufficient detail plans to collaborate with other IPP partners.

4. An evaluation plan should be included and describe ways to measure process and impact of expanded targeted CT/GC screening and treatment activities.

Additional requirements for additional documentation with the application are listed in Section VII. Award Administration Information, subsection entitled “Administrative and National Policy Requirements.”

APPLICATION SUBMISSION

Registering an organization through www.Grants.gov, the official agency-wide E-grant website, is the first step in submitting an application online. Registration information is located on the “Get Registered” screen of www.Grants.gov. Please visit www.Grants.gov at least 30 days prior to submitting an application to become familiar with the registration and submission processes. The “one-time” registration process will take three to five days to complete. However, the Grants.gov registration process also requires that the organization register with the Central Contractor Registry (CCR) annually. The CCR registration can require an additional one to two days to complete.

Submit the application electronically by using the forms and instructions posted for this funding opportunity on www.Grants.gov. If access to the Internet is not available or if the applicant encounters difficulty in accessing the forms on-line, contact the HHS/CDC Procurement and Grant Office Technical Information Management Section (PGO TIMS) staff at (770) 488-2700 for further instruction.

Note: Application submission is not concluded until successful completion of the validation process.

After submission of an application package, applicants will receive a “submission receipt” email generated by Grants.gov. Grants.gov will then generate a second e-mail message to applicants which will either validate or reject their submitted application package. This validation process may take as long as two (2) business days. Applicants are strongly encouraged check the status of their application to ensure submission of their application package is complete and no submission errors exists. To guarantee that an applicant has complied with the application deadline published in the Funding Opportunity Announcement, applicants are strongly encouraged to allocate additional days prior to the published deadline to file their application. Non-validated applications will not be accepted after the published application deadline date.

In the event that an applicant does not receive a “validation” email within two (2) business days of application submission, the applicant should contact Grants.gov. Refer to the email message generated at the time of application submission for instructions on how to track the application or the Application User Guide, Version 3.0 page 57.

Dun and Bradstreet Universal Number (DUNS)

The applicant is required to have a Dun and Bradstreet Data Universal Numbering System (DUNS) identifier to apply for grants or cooperative agreements from the Federal government. The DUNS is a nine-digit number which uniquely identifies business entities. There is no charge associated with obtaining a DUNS number. Applicants may obtain a DUNS number by accessing the Dun and Bradstreet website or by calling 1-866-705-5711. International registrants can confirm by sending an e-mail to ccrhelp@dnb.com, including Company Name, D-U-N-S Number, and Physical Address, and Country.

Electronic Submission of Application:

Applications must be submitted electronically at www.Grants.gov. Electronic applications will be considered as having met the deadline if the application has been successfully made available to CDC for processing from Grants.gov on the deadline date. The application package can be downloaded from www.Grants.gov. Applicants can complete the application package off-line, and then upload and submit the application via the Grants.gov Web site. The applicant must submit all application attachments using a PDF file format when submitting via Grants.gov. Directions for creating PDF files can be found on the Grants.gov Web site. Use of file formats other than PDF may result in the file being unreadable by staff.

Applications submitted through Grants.gov (http://www.grants.gov), are electronically time/date stamped and assigned a tracking number. The AOR will receive an e-mail notice of receipt when Grants.gov receives the application. The tracking number serves to document submission and initiate the electronic validation process before the application is made available to CDC for processing.

If the applicant encounters technical difficulties with Grants.gov, the applicant should contact Grants.gov Customer Service. The Grants.gov Contact Center is available 24 hours a day, 7 days a week, with the exception of all Federal Holidays. The Contact Center provides customer service to the applicant community. The extended hours will provide applicants support around the clock, ensuring the best possible customer service is received any time it’s needed. The Grants.gov Support Center can be reached at 1-800-518-4726 or by email at support@grants.gov. Submissions sent by e-mail, fax, CD’s or thumb drives of applications will not be accepted.

Organizations that encounter technical difficulties in using www.Grants.gov to submit their application must attempt to overcome those difficulties by contacting the Grants.gov Support Center (1-800-518-4726, support@grants.gov). After consulting with the Grants.gov Support Center, if the technical difficulties remain unresolved and electronic submission is not possible to meet the established deadline, organizations may submit a request prior to the application deadline by email to GMO/GMS for permission to submit a paper application. An organization's request for permission must: (a) include the Grants.gov case number assigned to the inquiry, (b) describe the difficulties that prevent electronic submission and the efforts taken with the Grants.gov Support Center (c) be submitted to the GMO/GMS at least 3 calendar days prior to the application deadline. Paper applications submitted without prior approval will not be considered.

If a paper application is authorized, the applicant will receive instructions from PGO TIMS to submit the original and two hard copies of the application by mail or express delivery service.

Submission Dates and Times

This announcement is the definitive guide on LOI and application content, submission, and deadline. It supersedes information provided in the application instructions. If the application submission does not meet the deadline published herein, it will not be eligible for review and the applicant will be notified the application did not meet the submission requirements.

Application Deadline Date: March 21, 2011, 5:00pm Eastern Standard Time VI. Application Review Information

Eligible applicants are required to provide measures of effectiveness that will demonstrate the accomplishment of the various identified objectives of the CDC-RFA-PS09-902. Measures of effectiveness must relate to the performance goals stated in the “Purpose” section of this announcement. Measures of effectiveness must be objective, quantitative and measure the intended outcome of the proposed program. The measures of effectiveness must be included in the application and will be an element of the evaluation of the submitted application.

Evaluation Criteria Each application will be evaluated individually. Only information in the application will be considered. Applications will not be reviewed by an objective review panel but by a structured review which will evaluate complete and responsive applications according to the criteria listed below.

Eligible applications will be evaluated against the following criteria:

The criteria against which the applications will be rated and the number of points allocated to each component of the application are listed below.

1.

Program Plan (40 points)

a. Does the applicant provide a brief description of the project area’s CT/GC epidemiology? (20 points)

b. Does the applicant describe how they intend to use their local data to plan targeted CT/GC screening and treatment activities? (20 points)

2. Program Experience and Organizational Capacity (20 Points)

Is the applicant’s program experience relevant to the planning, delivery, and evaluation of targeted CT/GC screening and treatment? (20 points)

3. Collaboration (20 points) Does the applicant describe in sufficient detail the plans to collaborate with other IPP partners? (20 points)

4.

Evaluation Plan (20 points)

Does the evaluation plan describe ways to measure process and impact of expanded targeted CT/GC screening and treatment activities? (20 points) All total (100 Points)

Budget (SF 424A) and Budget Narrative (Reviewed, but not scored) Although the budget is not scored applicants should consider the following in development of their budget. Is the itemized budget for conducting the project, and justification reasonable and consistent with stated objectives and planned program activities?

If the applicants requests indirect costs in the budget, a copy of the indirect cost rate agreement is required. If the indirect cost rate is a provisional rate, the agreement should be less than 12 months of age. The indirect cost rate agreement should be uploaded as a PDF file with “Other Attachment Forms” when submitting via Grants.gov.

Funding Restrictions Restrictions, which must be taken into account while writing the budget, are as follows:

· Recipients may not use funds for research.

· Recipients may not use funds for clinical care.

· Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual.

· Awardees may not generally use HHS/CDC/ATSDR funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget.

· The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award to another party or provider who is ineligible.

· Reimbursement of pre-award costs is not allowed.

The applicant can obtain guidance for completing a detailed justified budget on the CDC website, at the following Internet address:

http://www.cdc.gov/od/pgo/funding/budgetguide.htm.

Application Review Process

All eligible applications will be initially reviewed for completeness by the Procurement and Grants Office (PGO) staff. In addition, eligible applications will be jointly reviewed for responsiveness by NCHHSTP/DSTDP and PGO. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicants will be notified the application did not meet eligibility and/or published submission requirements.

Applications Selection Process

All eligible applicants submitting complete applications will be funded.

VII. Award Administration Information Award Notices

Successful applicants will receive a Notice of Award (NoA) from the CDC Procurement and Grants Office. The NoA shall be the only binding, authorizing document between the recipient and CDC. The NoA will be signed by an authorized Grants Management Officer and e-mailed to the program director. A hard copy of the NoA will be mailed to the recipient fiscal officer identified in the application.

Unsuccessful applicants will receive notification of the results of the application review by mail.

Administrative and National Policy Requirements

Successful applicants must comply with the administrative requirements outlined in 45 CFR Part 74 and Part 92, as appropriate. The following additional requirements apply to this project:

· AR-6

Patient Care

· AR-7

Executive Order 12372

· AR-8

Public Health System Reporting Requirements

· AR-9

Paperwork Reduction Act Requirements

· AR-10

Smoke-Free Workplace Requirements

· AR-11

Healthy People 2010

· AR-12

Lobbying Restrictions

· AR-14

Accounting System Requirements

· AR-23

States and Faith-Based Organizations

· AR-24

Health Insurance Portability and Accountability Act Requirements

· AR-25

Release and Sharing of Data

· AR-29

Compliance with E.O. 13513 Federal Leadership on Reducing

Text Messaging While Driving, October 1, 2009.

Additional information on the requirements can be found on the CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/Addtl_Reqmnts.htm.

CDC Assurances and Certifications can be found on the CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/grants/foamain.shtm For more information on the Code of Federal Regulations, see the National Archives and Records Administration at the following Internet address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html

TERMS AND CONDITIONS

Reporting Requirements

Each funded applicant must provide CDC with an annual Interim Progress Report submitted via www.grants.gov:

1. The interim progress report is due no less than 90 days before the end of the budget period. The Interim Progress Report will serve as the non-competing continuation application, and must contain the following elements:

a. Standard Form (“SF”) 424S Form.

b. SF-424A Budget Information-Non-Construction Programs.

c. Budget Narrative.

d. Indirect Cost Rate Agreement.

e. Project Narrative.

Additionally, funded applicants (grantees) must provide CDC with an original, plus two hard copies of the following reports:

2. Financial Status Report (SF 269) and annual progress report, no more than 90 days after the end of the budget period.

3. Final performance and Financial Status Reports, no more than 90 days after the end of the project period.

These reports must be submitted to the attention of the Grants Management Specialist listed in the Section VIII below entitled “Agency Contacts”.

VIII. Agency Contacts

CDC encourages inquiries concerning this announcement.

For programmatic technical assistance, contact:

Steven J Shapiro, Project Officer

Department of Health and Human Services

Centers for Disease Control and Prevention

Program and Training Branch, Division of STD Prevention

1600 Clifton Road, NE, Mail Stop E-27

Atlanta, GA 30333

Telephone: 404-639-8868

E-mail: sjs4@cdc.gov For financial, grants management, or budget assistance, contact:

Sheila Edwards, Grants Management Specialist

CDC Procurement and Grants Office

2920 Brandywine Road, Room 3728

Atlanta, GA 30341-4146

Telephone: 770-488-1644

E-mail: fyq5@cdc.gov For assistance with submission difficulties (also see page 12), contact:

Grants.gov Contact Center Phone: 1-800-518-4726.

Hours of Operation: 24 hours a day, 7 days a week. Closed on federal holidays.

For submission questions, contact:

Technical Information Management Section

CDC Procurement and Grants Office

2920 Brandywine Road, MS E-14

Atlanta, GA 30341

Telephone: 770-488-2700

Email:

pgotim@cdc.gov CDC Telecommunications for the hearing impaired or disabled is available at:

TTY 1-888-232-6348

Other Information

Other CDC funding opportunity announcements can be found at www.grants.gov.

PAGE